Chronic Schizophrenia Clinical Trial
Official title:
Nintendo Wii and Schizophrenia. A Pilot Study.
The purpose of this study is to determine whether the use of Nintendo Wii will help improve negative symptoms of Schizophrenia and quality of life of patients with chronic Schizophrenia.
The proposed study seeks to determine whether any benefit in daily functioning and quality
of life can be gained from using the Nintendo Wii video game console in chronic mental
illness, namely schizophrenia. There is a small research base on the use of the Wii console
in elderly nursing home residents as a means of increasing mobility, with attendant benefits
in areas such as falls, quality of life, and relief of subsyndromal depression. For
individuals with schizophrenia, adjunct exercise therapy has been associated with gains in
both psychiatric and physical symptoms. However, people with schizophrenia face physical and
functional barriers in initiating and continuing organized activity programs. Thus, the
Nintendo Wii Fit Plus interactive fitness video game is being proposed as a novel way of
introducing and engaging people with schizophrenia in various forms of physical activity.
As the first study to assess the use of the Nintendo Wii in chronic mental illness, the
purpose of this pilot study is to assess the feasibility and the capacity of the Nintendo
Wii in improving the health and functioning of people with severe, chronic schizophrenia.
Although it is hypothesized that Nintendo Wii use will lead to gains in these domains, the
information gained from this study will be used to determine specific areas of benefit and
to assess whether any observed differences in outcome measures are sufficient to warrant a
full-scale study. Furthermore, this initial study aims to pilot the interview schedule,
clarify wording on the questionnaires, ensure that all important areas have been covered by
the questionnaires, and determine whether participants are capable of meeting the demands of
the study.
;
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00161044 -
An Open-Label Investigation of the Adjuvant Therapeutic Effects of Galantamine in Patients With Chronic Schizophrenia and Persistent Deficit Symptoms
|
N/A | |
| Completed |
NCT01450514 -
POC Study of Pipamperone Added to Stable Treatment With RIS or PAL in Chronic Schizophrenia
|
Phase 2 | |
| Completed |
NCT05809882 -
Study of Experience of High-frequency Repetitive Transcranial
|
N/A | |
| Recruiting |
NCT05948696 -
Experience of Horticultural Group Therapy Among People With Chronic Schizophrenia
|
||
| Completed |
NCT06206798 -
Resourcefulness Group Intervention on Recovery and Quality of Life
|
N/A | |
| Completed |
NCT01891929 -
Cognitive Remediation and Sheltered Employment in Schizophrenia
|
N/A | |
| Completed |
NCT03275909 -
Integrated Psychological Therapy for Chronic Schizophrenia
|
N/A | |
| Completed |
NCT02298985 -
Curcumin Addition to Antipsychotic Treatment in Chronic Schizophrenia Patients
|
Phase 4 | |
| Recruiting |
NCT00525863 -
Oxygen Therapy in Schizophrenia
|
Phase 3 | |
| Completed |
NCT02624167 -
A Study to Determine the Safety, Tolerability and Efficacy NW-3509A in Patients With Chronic Schizophrenia
|
Phase 2 | |
| Completed |
NCT00789698 -
Lurasidone HCl - A Long Term Phase 3 Study of Patients With Chronic Schizophrenia
|
Phase 3 | |
| Recruiting |
NCT06349369 -
Effect of tDCS on Inflammatory Biomarkers in Chronic Schizophrenia
|
N/A | |
| Completed |
NCT02421146 -
The Effect of Transcranial Direct Current Stimulation on Human Brains: A Neuroimaging Study
|
N/A | |
| Active, not recruiting |
NCT00664274 -
Relation of Catechol-O-methyltransferase (COMT) Genotype and Response to Cognitive Remediation Schizophrenia
|
N/A | |
| Terminated |
NCT00148616 -
Memantine for the Treatment of Cognitive Dysfunction and Negative Symptoms in Patients With Chronic Schizophrenia
|
Phase 3 |